Recombinant preparations of the cytokine interferon (IFN)-α are increasingly used to treat a
number of medical conditions, including chronic viral hepatitis and several malignancies …

Interferon (IFN)-α, IFN-β, and IFN-γ are currently available for the treatment of malignancies,
viral infections (eg, hepatitis C virus), multiple sclerosis (MS), and skin conditions. In addition …

Background: Depression is among the commonest of psychiatric disorders, and
inflammatory mechanisms have been suggested to play a role in its pathophysiology …

We studied 60 patients receiving a 1-year course of interferon (IFN)-αtherapy for chronic
viral hepatitis. Patients underwent psychiatric assessment before starting the IFN-αtherapy …

Major Depressive Disorder (MDD) during interferons (IFN-α) treatment can occur within a
few months of therapy, and shares many homologies with other forms of MDD, Most patients …

Interferon alpha (IFNα) is used for the treatment of several disorders, such as chronic
hepatitis or malignant melanoma. During the therapy, IFNα may cause severe …

Abstract Interferon alpha (IFN-α)-treated patients commonly develop depression during the
therapy period. Although most IFN-α-induced depressive disorders achieve remission after …

Interferon-alpha IFN-α) is a cytokine with strong antiviral and antiproliferative properties. IFN-
α is the only effective treatment for chronic hepatitis C and the first substance that shows …

Abstract Interferon (IFN)-alpha, until recently the standard treatment of hepatitis C virus
(HCV) infection, is associated with a significant risk of major depressive episode (MDE, or …

Psychiatric disorders, especially depression, are frequent in patients with multiple sclerosis
(MS). They are attributed both to the psychosocial impact of a chronic, usually progressive …